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Primary dysmenorrhoea is painful menstrual cramps of uterine origin during menstruation without any identifiable 
pathological lesion. It is commonly seen in menstruating and lasting 12-24 h. Its prevalence is wide, as more than 70% of 
teenagers and 30-50% of menstruating women suffer from varying degree of discomfort. Tibbe-e-Unani claims to possess 
safe and effective therapeutic substances which are commonly prescribed in the management of primary dysmenorrhoea 
(Usr-e-Tams Ibtedayee), but despite being used in the treatment successfully, most of them have yet not been studied 
scientifically. Therefore, an attempt has been made in the present study to evaluate a single Unani drug Tukhm-e-Sambhalu 
(Vitex negundo) on 30 patients for its efficacy in primary dysmenorrhoea. The patients were administered test drug in 
powder form (5 g), by oral rout, twice a day for 7 days, starting 2 days before the onset of menstruation up to 5th day of 
menses, for three consecutive cycles. The important clinical features like pain in suprapubic region, pain in thigh, backache 
and headache were significantly reduced in patients treated with test drug. Thus, findings of this study suggested that 
Tukhm-e-Sambhalu is safe and effective in ameliorating the disease primary dysmenorrhoea. 
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Dysmenorrhoea (Usr-e-Tams) means painful 
menstruation1. It is derived from the Greek word Dys, 
meaning difficult/ painful/abnormal; mens meaning 
month and rrhoea meaning flow2. Dysmenorrhoea may 
affect more than half of menstruating women3,4. In 
classical Unani literature, it has been described that 
Usr-e-Tams (dysmenorrhoea) is a variety of Waja-e-
Rahem (uterine pain) that causes due to menstruation5. 
It is a major medical problem not only for women but 
also for their families and health sciences6. It is a major 
cause of absenteeism from work thus decreasing 
efficiency and quality of life among the affected 
women7,8. It is a common gynaecological complaint9, 
with severe painful cramping sensation in the lower 
abdomen. It is often accompanied by other associated 
symptoms including sweating, tachycardia, headache, 
nausea, vomiting and diarrhoea, all occurring before or 
during the menstruation10. It is of two types. The pain 
which is of uterine origin and directly linked to 
menstruation but with no visible pelvic pathology, is 
known as primary (Ibtedayee) or true dysmenorrhoea 
and pain which is associated with pelvic pathology, is 
said to be secondary (saanwi) dysmenorrhoea1. 
Primary dysmenorrhoea (Usr-e-Tams Ibtedayee) is a 
common gynecological complain. It is painful 
menstrual cramps of uterine origin during menstruation 
without any identifiable pathological lesion6,11-13. It 
usually appears within 1-2 years of menarche, when 
ovulatory cycles are established. This disorder affects 
the younger females but may persist into the 40s11. It 
affects more than 50% of post pubescent stage in 
women of 18-25 years of age groups. It is common in 
adolescent and characterized by spasmodic pain 
beginning with onset of menstruation and lasting 12-24 
h. It is prevalent widely, as more than 70% of teenagers 
and 30-50% of menstruating women experience from 
varying degrees of discomfort. Only about 5-15% of 
populations are affected by severe incapacitating type 
which interferes with women’s daily activities3. The 
pain arises in uterus and it is related to muscle 
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contraction and colicky in type. It is felt mainly in 
hypogastrium and often referred to inner and front 
aspects of thighs12. Other symptoms are uterine 
cramping, nausea, vomiting, backache, diarrhea, 
giddiness, syncope and fainting. Now, it is very clear 
that pathogenesis of menstrual pain is attributable to 
biochemical derangement3. Prostaglandins and 
arachidonic acid metabolites have an important role in 
the development of dysmenorrhoea6. Women of 
primary dysmenorrhoea were shown to have higher 
level of prostaglandin (PG) of endometrial and 
menstrual fluid than those women without this 
problem. Prostaglandin acts directly on myometrium 
(uterine musculature) to increase basal intrauterine 
pressure and intensity and frequency of myometrial 
contraction. They also cause contraction of uterine 
arteries with tissue ischemia and pain. Finally, PGE2 
may increase the sensitivity of peripheral pain fibers14. 
For the action of prostaglandin, the endometrium has to 
prime by estrogen followed by progesterone. That is 
why primary dysmenorrhoea is usually experienced in 
ovulatory cycles1.  
In spite of high prevalence of primary 
dysmenorrhoea, the choice of management available 
in western medicine is very less. Even the substances 
available for the purpose are not without side effects. 
The disease is usually treated with prostaglandin 
synthetase inhibitor (NSAID) and oral contraceptives 
that possess their own side effects such as headache, 
peptic ulceration, gastric irritation, erosion, chronic renal 
failure, hepatic failure, bleeding, skin rashes, asthma, 
weight gain, hypertension, vascular complications etc15. 
This situation justifies some alternative layout for the 
management of primary dysmenorrhoea. Unani 
medicine claims to possess effective and safe substances 
which can be therapeutically used in the management of 
Usr-e-Tams Ibtedayee, but they have not been 
scientifically evaluated on scientific parameters. Tukhm-
e-Sambhalu (Vitex negundo Linn. seed) is one such 
drug which possesses musakhkhin, mudirr-e-haiz, 
mulaiyan16, mohallil, musakkin17, mulattif and qabiz18 
properties and described to be effective in Usr-e-
Tams19. Therefore, a scientific study has been 
designed to evaluate possible efficacy of this drug in 
participants diagnosed with conformity to be suffering 
from Usr-e-Tams Ibtedayee. 
 
Methodology 
The women visited the OPD of Department of 
Ilmul Qabalat wa Amraz-e-Niswan, Mohammadia 
Tibbia Collage and Assayer Hospital, Mansoora, 
Malegaon, during 2014-2016, were screened for the 
Usr-e-Tams Ibtedayee (primary dysmenorrhoea) 
based on clinical signs and symptoms. 
After taking the informed consent, 60 patients of 
reproductive age group (14-37) diagnosed with this 
disease were involved in this study. They were 
enlightened about this disease, examination 
performed and treatment given. The women suffering 
from any organic pelvic pathology, metabolic and 
hormonal disorders, sensitivity to NSAID and any 
systemic diseases like hypertension, diabetes mellitus 
and sexually transmitted diseases, were eliminated 
from this study. Prior to the initiation of this clinical 
study, permission from Institutional Ethics Committee 
(IEC) was obtained. With the help of computer 
randomized tables/ numbers, the patients were divided 
(Table 1) into two groups of 30 cases each. The 
patients in group of standard control (group I), were 
treated with one Tab Combiflam (Paracetamol 325 
mg + Ibuprofen 400 mg), two times a day after meal 
orally, from starting of menstruation up to 3 days, for 
three successive menstrual cycles, to compare the 
study. While the women in group II (test group), were 
administered with powder of Vitex negundo Linn seed 
(Tukhm-e-Sambhalu), in a dose of 5 g, orally twice a 
day for one week, starting earlier 2 days of menstrual 
period up to 5th day of menses, for three consecutive 
cycles. The test drug was obtained from local traders, 
dehydrated at room temperature and reduced to course 
powder by grinding. 
The patients were advised for follow up before and 
after each menstrual period of the cycles during 
treatment. The changes in clinical features of all the 
patients were documented for evaluation. At each 
visit patients were cautiously interrogated and their 
statements about the painful menstruation, pain in 
suprapubic region, pain in thighs, backache, nausea or 
vomiting, diarrhoea, headache and syncope/fainting 
were recorded. 
Certain investigations such as HB%, TLC, DLC, 
ESR, random blood sugar, blood urea, serum 
creatinine, SGOT, SGPT, alkaline phosphatase, 
VDRL, Pelvic USG, urine & stool examination and 
Table 1 — Treatment Schedule 
Group Drug Treatment Dose Duration 
Group I Tab. Combiflam 
(Paracetamol 325 mg + 
Ibuprofen 400 mg) 
1 Tablet x 
BD 
3 Days x 
3 Menstrual 
cycle 
Group II Tukhm-e-Sambhalu  
powder 
5 gm x BD 7 Days x 
3 Menstrual 
cycle 




pap smear in selected cases were done to establish the 
safety of the drug and to exclude the patients other 
than primary dysmenorrhoea. These investigations 
were carried out before starting and after stopping the 
treatment. 
On every follow up all the symptoms and signs 
were sorted on point scales and changes were 
documented in case record form. The findings were 
recorded on a computerized proforma. Lastly,  
recorded observations were statically analyzed by chi 
square test. 
 
Results and discussion 
The efficacy of test drug in primary dysmenorrhoea 
was explored by observing clinical features. The 
observations were recorded, analyzed and compared 
with the standard drug (Table 2). Prior to the 
treatment pain in suprapubic region was observed in 
all (100%) the cases involved in the study, whereas 
after medication it was significantly reduced and 
persisted only in 36.66% and 53.33% of the cases and 
recovery was recorded in 63.33% and 46.66% of the 
case in group I and group II, respectively. Pain in the 
thigh on day of registration was recorded in 80% and 
86.66% of the case in group I and II, respectively, 
while after therapy it has significantly decreased to 
33.33% and 42.30% of the case and recovery was 
noted in 66.66% and 57.69% of the case, respectively. 
Before the treatment backache was noted in 76.66% 
and 86.66% in the group I and II, while after 
medication it has significantly decreased and 
remained only in 21.73% and 42.30% of patient and 
recovery was recorded in 78.26% and 57.69% of the 
case in group I and II, respectively. Before the therapy 
headache was recorded in 16.66% and 10% of case in 
group I and II, respectively, while after medication it 
has significantly reduced and totally disappeared in 
both the groups. On the day zero, Nausea/vomiting 
was observed in 6.66% and 13.33% of the case in 
group I and II, respectively, while after therapy it has 
significantly decreased and noted only in 50% and 
25% of patient and recovery was recorded in 50% and 
75% of case in group I and II, respectively. Prior to 
treatment syncope was observed in 3.33% and 6.66% 
of case in group I and II, respectively. While after 
medication it has significantly decreased and 
disappeared completely and 100% recovery was noted 
in group I but in group II, it was reduced to 50% and 
improvement was observed in 50% of the patients. 
The findings of present study discovered that 
Tukhm-e-Sambhalu (Vitex negundo Linn. seed) is 
beneficial in relieving the symptoms and signs of Usr-
e-Tams Ibtedayee (primary dysmenorrhoea), that is 
proved by decreasing suprapubic regionpain, 
thighpain, backache and headache. It was observed 
that all the parameters significantly recovered 
advocating that oral intake of Vitex negundo seed in 
the treatment of primary dysmenorrhoea is quite 
efficacious. Thus, this study validated the medicinal 
treatment recommended by Unani practitioners in the 
treatment of primary dysmenorrhoea. 
In this study Vitex negundo is almost as effective as 
Combiflam. According to Najmul Ghani, Tukhm-e-
Sambhalu cures all menstrual problems19. The effect 
of Sambhalu (Vitex negundo) was owing to its 
musakkin (anodyne), mohallil (anti-inflammatory)17, 
daf-e-alam (analgesic), moarrique (diaphoretic)19, 
mudirr-e-haiz (emmenagogue) and musakhkhin 
(calorific) properties16. It is also pharmacologically 
proved for analgesic effects and action on  
central nervous system20, anti-nociceptive21,  
anti-inflammatory22, deobstruent23, diuretic, 
emmenagogue, nerve tonic24, analgesic and 
tranquillizing effects (Anonymous, 1976). Tandon 
and Gupta states that prostaglandin inhibition and 
reduction of oxidative stress are responsible for 
analgesic effect and this is not mediated through 
opioid receptors21. Telang et al. explained that 
Table 2 — Effect of drug on clinical features 
Clinical features Group I (Standard Control) Group II (Test) 
Baseline Post 
Treatment 
Improvement Baseline Post 
Treatment 
Improvement 
N % N % N % N % N % N % 
Pain in suprapubic region 30 100 11 36.66 19 63.33 30 100 16 53.33 14 46.66 
Pain in thigh 24 80 08 33.33 16 66.66 26 86.66 11 42.33 15 57.69 
Backache 23 76.66 05 21.73 18 78.26 26 86.66 11 42.30 15 57.69 
Headache 05 16.66 00 00 05 100 03 10 00 00 03 100 
Nausea / vomit 02 6.66 01 50 01 50 04 13.33 01 25 03 75 
Syncope 01 3.33 00 00 01 100 02 6.66 01 50 01 50 




prostaglandin synthesis inhibition of fresh leaves 
attributed anti-inflammatory and pain suppressing 
activities 26. An aqueous extract of the fruits of Vitex 
negundo found to have good analgesic action, when 
tested on rats, by analgesiometric method25. 
In the pathogenesis of dysmenorrhoea, 
prostaglandin (PG) and arachiodonic acid metabolites 
have an important role 6. The menstrual cramps 
intensity and dysmenorrhoea’s associated symptoms 
are directly proportional to the released quantity of 
PGF2 α. During first two days of menstruation 
maximum amount of prostaglandin is released, that is 
equal to time of maximum discomfort14. 
Prostaglandins are recognized to increase the 
contraction of myometrium and also small 
endometrial blood vessels constrictionsthat produces 
endometrial ischemia and its breakdown leads to 
bleeding and pain. Increase of Prostaglandin E2 level 
increases the nerve endings sensitivity to pain12. The 
pain is usually associated with prostaglandin. Women 
suffering from this pain have higher concentration of 
PGF2 in menstrual blood. PGE2 causes uterine 
concentration, cervical narrowing, increase in 
vasopressin release which causes ischemia and pain. 
Thus, suppression of PG production cures the 
problems6. Although in Unani literature the exact 
mechanism of action has not been explained but the 
pharmacological activities expressed in Unani 
medicine have been validated by various researchers 
suggesting that the basis of therapy as explainedin 
classical literature of Unani medicine is in conformity 
with the scientific reports of recent studies. Therefore, 
the mechanism of action proposed in scientific 
studies6,14 may be the pharmacological basis of 
efficacy of test drug in cases of dysmenorrhoea. 
 
Conclusion 
It can be concluded in the light of above results and 
discussion, that seeds of Vitex negundo (Tukhm-e-
Sambhalu) possess significant level of efficacy in 
Usr-e-Tams Ibtedayee (primary dysmenorrhoea), that 
is mentioned in ethno-botanical and classic Unani 
literature. It may be used effectively in patients 
affected with primary dysmenorrhoea. It is also 
observed that it is well tolerated by the patients 
without having any type of side effects. Therefore, 
this study scientifically authenticates the therapeutics 
application of Vitex negundo seed in cases of primary 
dysmenorrhoea. However, for further research more 
elaborative and extensive studies should be done for 
the exact mechanism of action of the test drug. 
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